Colegado, Lovie John .
HRN: 24-38-30 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/12/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/12/2024
01/18/2024
IVT
500mg
Q8hrs
Pelvic Abscess
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes